- Home
- SCOR vs UBX Comparison
SCOR vs UBX Comparison
Compare SCOR & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCOR
- UBX
- Stock Information
- Founded
- SCOR 1999
- UBX 2009
- Country
- SCOR United States
- UBX United States
- Employees
- SCOR N/A
- UBX N/A
- Industry
- SCOR Business Services
- UBX Biotechnology: Pharmaceutical Preparations
- Sector
- SCOR Consumer Discretionary
- UBX Health Care
- Exchange
- SCOR Nasdaq
- UBX Nasdaq
- Market Cap
- SCOR 34.7M
- UBX 36.9M
- IPO Year
- SCOR 2007
- UBX 2018
- Fundamental
- Price
- SCOR $6.64
- UBX $1.94
- Analyst Decision
- SCOR Buy
- UBX Strong Buy
- Analyst Count
- SCOR 3
- UBX 2
- Target Price
- SCOR $12.83
- UBX $7.00
- AVG Volume (30 Days)
- SCOR 27.4K
- UBX 203.3K
- Earning Date
- SCOR 03-05-2025
- UBX 04-14-2025
- Dividend Yield
- SCOR N/A
- UBX N/A
- EPS Growth
- SCOR N/A
- UBX N/A
- EPS
- SCOR N/A
- UBX N/A
- Revenue
- SCOR $356,212,000.00
- UBX N/A
- Revenue This Year
- SCOR N/A
- UBX N/A
- Revenue Next Year
- SCOR $2.92
- UBX $33.62
- P/E Ratio
- SCOR N/A
- UBX N/A
- Revenue Growth
- SCOR N/A
- UBX N/A
- 52 Week Low
- SCOR $4.89
- UBX $0.94
- 52 Week High
- SCOR $20.42
- UBX $3.10
- Technical
- Relative Strength Index (RSI)
- SCOR 43.65
- UBX 48.69
- Support Level
- SCOR $6.92
- UBX $1.99
- Resistance Level
- SCOR $7.44
- UBX $2.17
- Average True Range (ATR)
- SCOR 0.59
- UBX 0.22
- MACD
- SCOR -0.13
- UBX -0.05
- Stochastic Oscillator
- SCOR 8.09
- UBX 22.41
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. The platforms measure include televisions, mobile devices, computers, tablets, CTV devices and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada and Others. It provides solutions for Automotive, Digital Media, Financial Services, FMCG, Pharmaceutical , Retail, Technology and Travel.
About UBX Unity Biotechnology Inc.
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.